The first third-generation drug-eluting stent is now available to physicians and patients in many markets around the world, including countries in Western and Eastern Europe, Asia Pacific and the Middle East. Cordis Corp. expects to offer the CYPHER SELECT Plus Stent in most markets outside the U.S. and Japan within the next two quarters.
